<div><div></div><div>SXTP (60 Degrees Pharmaceuticals, Inc.) is set to announce its Q1'26 results on May 14, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 435.00 thousand USD with EPS (earnings per share) anticipated at (0.76) USD. Learn more details at .Revenue &amp; EPS values are provided in USD<div><table><thead><tr><th></th><th>Q1'25</th><th>Q2'25</th><th>Q3'25</th><th>Q4'25</th><th>Q1'26</th></tr></thead><tbody><tr><td>Revenue Reported</td><td>163.60 K</td><td>305.00 K</td><td>500.00 K</td><td>300.00 K</td><td>—</td></tr><tr><td>Revenue Estimate</td><td>300.00 K</td><td>320.00 K</td><td>200.00 K</td><td>320.00 K</td><td>435.00 K</td></tr><tr><td>Revenue Surprise</td><td>-45.47%</td><td>-4.69%</td><td>+150.00%</td><td>-6.25%</td><td></td></tr><tr><td>EPS Reported</td><td>(6.24)</td><td>(4.82)</td><td>(2.67)</td><td>(1.91)</td><td></td></tr><tr><td>EPS Estimate</td><td>(5.26)</td><td>(4.96)</td><td>(1.84)</td><td>(1.47)</td><td>(0.76)</td></tr><tr><td>EPS Surprise</td><td>-18.63%</td><td>+2.82%</td><td>-45.11%</td><td>-29.93%</td><td></td></tr></tbody></table></div><section>Disclaimer<div>Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.</div></section></div></div>

SXTP

ARKG

SBIO

LABU

SXTP (60 Degrees Pharmaceuticals, Inc.) will announce its Q1'26 earnings on May 14 at 8:00 AM ET. The revenue estimate is $435,000, with an anticipated EPS of $(0.76). Previous quarters showed significant revenue surprises and varying EPS results. For Q1'25, reported revenue was $163.60K, and for Q4'25, it was $300K. The EPS has shown a downward trend, with reported values ranging from $(6.24) to $(1.91) in the last four quarters.

SXTP Q1'26 Earnings: EPS estimate is (0.76) USD